For my $5.50 lifetime ScsDriver WebDAV mount tool, I tested 3 months of a "free trial + invite-extend" strategy. Result: 200 signups/month, K-factor 1.2, 54% trial-to-paid, zero CAC. Here's the playbook.
The core problem
New tiny SaaS faces a paradox: free trial drives signups but burns runway. Paid-only kills word-of-mouth. How to balance?
For $5.50 lifetime ScsDriver, the answer was: paid lifetime ($5.50) + 7-day trial + invite-extension (+7 days per invite).
Why paid lifetime $5.50 (not subscription, not free)
Three reasons:
- Subscription kills word-of-mouth for tiny SaaS. Users don't tell friends "subscribe to my $5/month tool". They tell friends "buy this $5.50 thing, it's lifetime". Subscription is mental friction for $5.
- Free tier gets exploited. 99% of "free" users never convert. Server costs pile up. Team burns out. Free is a trap.
- $5.50 is below decision threshold. Users don't think twice about $5.50 (5 USD). They think twice about $9.99. They think 10x about $19.99.
For tiny SaaS, $5.50 lifetime hits the sweet spot: low CAC impulse buy + high conversion + zero churn (you can't churn a lifetime purchase).
The free trial extension mechanism
The trial extension:
- 7-day free trial on signup
- Each invite = +7 days trial extension
- Inviter must actually register (not just click)
- No upper limit on invites (K-factor ceiling is organic)
Why this works:
- Users self-spread (to keep using, they bring friends)
- K-factor > 1 means self-replicating (each user brings >1 new user on average)
- Paid conversion goes UP (users who extend trial feel invested)
- Zero CAC (users do the marketing)
Real numbers (3 months measured)
- Trial signups: 200/month
- Avg invites per user: 1.5
- K-factor: 1.2 (each user brings 1.2 new users on average)
- Viral coefficient: positive (>1)
- Trial-to-paid conversion: 54%
- CAC: $0 (organic viral)
Compare to paid ads (Google Ads test):
- $0.85 CPC, 1.2% conversion, $71 CPA
- Negative ROI on $5.50 product
Viral + paid lifetime beats ads by 10x+ for small-lifetime products.
The 4 strategies that prevent bankruptcy
Strategy 1: Paid lifetime + ultra-low price
$5.50 lifetime + no subscription + no free tier:
- Higher paid conversion (no free alternative)
- Higher intent (users self-select to buy)
- Lower support cost (paid users self-serve)
- Zero churn (lifetime)
Strategy 2: Trial + invite extension
7-day trial + +7 days per invite:
- Self-spreading user base
- K-factor > 1 (organic growth)
- Viral coefficient stable
- Zero CAC
Strategy 3: Region-split pricing
US/overseas $5.50, CN ¥20 (~$2.80):
- Users not confused by pricing
- Platforms not punished for mixing prices
- SEO cleaner (Bing $5.50, Baidu ¥20)
- User tiers clear
Strategy 4: Anti-abuse
4 anti-abuse tactics:
- Invite must register (not just click)
- 1 IP = 1 account
- Paid users get features first
- Trial expiry = must buy (no permanent free)
Anti-patterns I tried (do not do)
Anti-pattern A: Fully free + micro-transactions (gacha-tier)
- 95% of users free-ride, <1% convert
- Server costs explode
- Team burns out
Anti-pattern B: Subscription ($5/month)
- Users hate subscription for cheap tools
- Long decision cycle (think for 1 month)
- High churn (sub users leave easily)
Anti-pattern C: High price ($99+ lifetime)
- Users think too long
- Low conversion (browse and leave)
- Slow word-of-mouth (users don't recommend expensive)
Anti-pattern D: Fully free + pop-up ads
- User experience terrible
- Massive churn
- Platform may ban (malicious ads)
The takeaway
For tiny SaaS, "free trial" doesn't have to burn money. The trick is design a system where:
- K-factor > 1 (users bring more users)
- Trial-to-paid > 50% (most users convert)
- CAC = $0 (organic viral)
- Paid tier is cheap enough to impulse-buy ($5.50)
For $5.50 lifetime ScsDriver, this delivers 200 signups/month, 54% conversion, zero CAC, positive K-factor. Total unit economics: revenue > cost, profitable from month 1.
If you only ship one growth change this month, add an invite-extension mechanism to your trial. Even at K-factor 0.5 (not 1.2), you cut CAC in half within 60 days.
Top comments (0)